Sunyoung S. Lee

The University of Texas MD Anderson Cancer Center

Also affiliated with ID Genomics (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 24 papers. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma

Journal of Hepatology(2023)10.1016/j.jhep.2023.10.041

N/A

1.0DataRank · unranked

36 citations

Ming Zhao, Kurt W. Evans, Kaushik Varadarajan, Tyler Moss, Stephen Scott +12 more

Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States

Cancer(2022)10.1002/cncr.34223

N/A

0.659DataRank · unranked

13 citations

Hop S. Tran Cao, Jean‐Nicolas Vauthey, Gohar Manzar, Kelsey L. Corrigan, Kanwal Raghav +12 more

Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial

Journal of Clinical Oncology(2024)10.1200/jco.24.00081

N/A

0.619DataRank · unranked

61 citations

Alexander D. Sherry, Bryan M. Fellman, Suyu Liu, Tharakeswara Bathala, Cara Haymaker +25 more

Genome-wide association study identifies high-impact susceptibility loci for HCC in North America

Hepatology(2024)10.1097/hep.0000000000000800

N/A

0.557DataRank · unranked

40 citations

Donghui Li, Younghun Han, Jinyoung Byun, Rikita Hatia, Erping Long +48 more

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma

Cancers(2022)10.3390/cancers14081901

N/A

0.538DataRank · unranked

35 citations

Brian De, Chike O. Abana, Sunyoung S. Lee, Milind Javle, Ahmed O. Kaseb +10 more

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget(2022)10.18632/oncotarget.28322

N/A

0.434DataRank · unranked

17 citations

Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao +13 more

Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae037

N/A

0.340DataRank · unranked

6 citations

Franklin C. Wong, Beth Chasen, William D. Erwin, Prajnan Das, Emma B. Holliday +27 more

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-6

N/A

0.330DataRank · unranked

8 citations

Betül Gök Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu +13 more

Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1233

N/A

0DataRank · unranked

1 citations

Kurt W. Evans, Stephen Scott, Xiaofeng Zheng, Kaushik Varadarajan, Lawrence N. Kwong +16 more

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response

medRxiv(2024)10.1101/2024.09.11.24313334

N/A

0DataRank · unranked

5 citations

Prashant Dogra, Mohamed Zaid, Dalia Elganainy, Kevin Sun, Ahmed Amer +26 more

Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0829

N/A

0DataRank · unranked

1 citations

Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju‐Seog Lee +1 more

Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0828

N/A

0DataRank · unranked

0 citations

Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Peng Wei +2 more

Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0830

N/A

0DataRank · unranked

0 citations

Sung-Hwan Lee, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju‐Seog Lee +1 more

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response

npj Systems Biology and Applications(2025)10.1038/s41540-025-00616-9

N/A

0DataRank · unranked

0 citations

Prashant Dogra, Mohamed Zaid, Dalia Elganainy, Kevin Sun, Ahmed Amer +26 more

Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0333

N/A

0DataRank · unranked

23 citations

Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang +10 more

IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.488

N/A

0DataRank · unranked

0 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +8 more

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases

Liver Cancer(2023)10.1159/000530134

N/A

0DataRank · unranked

13 citations

Rituraj Upadhyay, Kaiping Liao, Tiffany Kumala, Christopher Shi, Grace Dodoo +24 more

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis

The Oncologist(2023)10.1093/oncolo/oyac273

N/A

0DataRank · unranked

4 citations

Brian De, Sunyoung S. Lee, Joseph Abi Jaoude, Jean‐Nicolas Vauthey, Ching‐Wei D. Tzeng +14 more

Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features

The Oncologist(2023)10.1093/oncolo/oyad329

N/A

0DataRank · unranked

1 citations

Russell G. Witt, Khaled M. Elsayes, Ali Baiomy, Lianchun Xiao, Sarah Palmquist +14 more

Dose-escalated pancreas radiotherapy for unresected pancreatic adenocarcinoma: Patterns of care and survival in the United States.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.676

N/A

0DataRank · unranked

1 citations

Brian De, Marcus A. Florez, Hop Sanderson Tran Cao, Sunyoung S. Lee, Jason Willis +10 more

IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16660

N/A

0DataRank · unranked

1 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +9 more

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Cancer Biomarkers(2024)10.3233/cbm-230431

N/A

0DataRank · unranked

12 citations

Sunyoung S. Lee, Tarık Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao +17 more

Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?

Annals of Surgical Oncology(2024)10.1245/s10434-024-14939-0

N/A

0DataRank · unranked

7 citations

Mateo Lendoire, Artem Boyev, Timothy E. Newhook, Ching‐Wei D. Tzeng, Hop S. Tran Cao +8 more